1. Brevilin A Induces Cell Cycle Arrest and Apoptosis in Nasopharyngeal Carcinoma
   Rui Liu et al, 2019, Frontiers in Pharmacology CrossRef
2. Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors
   Geer Chen et al, 2022, Pharmacological Research CrossRef
3. Gambogic acid suppresses nasopharyngeal carcinoma via rewiring molecular network of cancer malignancy and immunosurveillance
   Tao Ren et al, 2022, Biomedicine & Pharmacotherapy CrossRef
4. Reduction-sensitive nanomicelles: Delivery celastrol for retinoblastoma cells effective apoptosis
   Zhihua Guo et al, 2021, Chinese Chemical Letters CrossRef
5. Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone‐methide triterpenoid celastrol
   Yun Lu et al, 2021, Medicinal Research Reviews CrossRef
6. Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity
   Junqi Zhao et al, 2021, Frontiers in Pharmacology CrossRef
7. Taurine exhibits an apoptosis-inducing effect on human nasopharyngeal carcinoma cells through PTEN/Akt pathways in vitro
   Feng He et al, 2018, Amino Acids CrossRef
8. Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in Mice
   Xinyan Chen et al, 2020, Molecular Pharmaceutics CrossRef
9. Rediscovery of NF‐κB signaling in nasopharyngeal carcinoma: How genetic defects of NF‐κB pathway interplay with EBV in driving oncogenesis?
   Mei Yi et al, 2018, Journal of Cellular Physiology CrossRef
10. Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology
    Wei Hou et al, 2020, European Journal of Medicinal Chemistry CrossRef
11. Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma
    Yen-Tze Liu et al, 2019, Biomedicine & Pharmacotherapy CrossRef
12. Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations
    Junjun Ling et al, 2022, Frontiers in Pharmacology CrossRef
13. Scaffold hopping of celastrol provides derivatives containing pepper ring, pyrazine and oxazole substructures as potent autophagy inducers against breast cancer cell line MCF-7
    Yao Feng et al, 2022, European Journal of Medicinal Chemistry CrossRef
14. Curcumol attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via TGF-β1
    Dazhong Yan et al, 2018, Molecular Medicine Reports CrossRef
15. Tripterygium hypoglaucum (Levl.) Hutch: A systematic review of its traditional uses, botany, phytochemistry, pharmacology, pharmacokinetics and toxicology
    Jiangping Wei et al, 2022, Pharmacological Research - Modern Chinese Medicine CrossRef
16. Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway
    Ming-Ju Hsieh et al, 2019, Phytomedicine CrossRef
17. Arnicolide D, from the herb Centipeda minima, Is a Therapeutic Candidate against Nasopharyngeal Carcinoma
    Rui Liu et al, 2019, Molecules CrossRef
18. Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study
    Ya Cao et al, 2021, Signal Transduction and Targeted Therapy CrossRef
19. Molecular targets of celastrol in cancer: Recent trends and advancements
    Dharambir Kashyap et al, 2018, Critical Reviews in Oncology/Hematology CrossRef
20. Celastrol induces vincristine multidrug resistance oral cancer cell apoptosis by targeting JNK1/2 signaling pathway
    Fu-Zhen Lin et al, 2019, Phytomedicine CrossRef